James M Kasper1, David L McCue1, Adrianna J Milton1, Angelia Szwed1, Catherine M Sampson1, Mei Huang2, Susan Carlton3, Herbert Y Meltzer2, Kathryn A Cunningham1, Jonathan D Hommel4. 1. Center for Addiction Research, Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, Texas. 2. Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, Illinois. 3. Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, Texas. 4. Center for Addiction Research, Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, Texas. Electronic address: jdhommel@utmb.edu.
Abstract
BACKGROUND: Neuromedin U (NMU) is a neuropeptide enriched in the nucleus accumbens shell (NAcSh), a brain region associated with reward. While NMU and its receptor, NMU receptor 2 (NMUR2), have been studied for the ability to regulate food reward, NMU has not been studied in the context of drugs of abuse (e.g., cocaine). Furthermore, the neuroanatomical pathways that express NMUR2 and its ultrastructural localization are unknown. METHODS: Immunohistochemistry was used to determine the synaptic localization of NMUR2 in the NAcSh and characterize which neurons express this receptor (n = 17). The functional outcome of NMU on NMUR2 was examined using microdialysis (n = 16). The behavioral effects of NMU microinjection directly to the NAcSh were investigated using cocaine-evoked locomotion (n = 93). The specific effects of NMUR2 knockdown on cocaine-evoked locomotion were evaluated using viral-mediated RNA interference (n = 40). RESULTS: NMUR2 is localized to presynaptic gamma-aminobutyric acidergic nerve terminals in the NAcSh originating from the dorsal raphe nucleus. Furthermore, NMU microinjection to the NAcSh decreased local gamma-aminobutyric acid concentrations. Next, we evaluated the effects of NMU microinjection on behavioral sensitization to cocaine. When repeatedly administered throughout the sensitization regimen, NMU attenuated cocaine-evoked hyperactivity. Additionally, small hairpin RNA-mediated knockdown of presynaptic NMUR2 in the NAcSh using a retrograde viral vector potentiated cocaine sensitization. CONCLUSIONS: Together, these data reveal that NMUR2 modulates a novel gamma-aminobutyric acidergic pathway from the dorsal raphe nucleus to the NAcSh to influence behavioral responses to cocaine.
BACKGROUND:Neuromedin U (NMU) is a neuropeptide enriched in the nucleus accumbens shell (NAcSh), a brain region associated with reward. While NMU and its receptor, NMU receptor 2 (NMUR2), have been studied for the ability to regulate food reward, NMU has not been studied in the context of drugs of abuse (e.g., cocaine). Furthermore, the neuroanatomical pathways that express NMUR2 and its ultrastructural localization are unknown. METHODS: Immunohistochemistry was used to determine the synaptic localization of NMUR2 in the NAcSh and characterize which neurons express this receptor (n = 17). The functional outcome of NMU on NMUR2 was examined using microdialysis (n = 16). The behavioral effects of NMU microinjection directly to the NAcSh were investigated using cocaine-evoked locomotion (n = 93). The specific effects of NMUR2 knockdown on cocaine-evoked locomotion were evaluated using viral-mediated RNA interference (n = 40). RESULTS:NMUR2 is localized to presynaptic gamma-aminobutyric acidergic nerve terminals in the NAcSh originating from the dorsal raphe nucleus. Furthermore, NMU microinjection to the NAcSh decreased local gamma-aminobutyric acid concentrations. Next, we evaluated the effects of NMU microinjection on behavioral sensitization to cocaine. When repeatedly administered throughout the sensitization regimen, NMU attenuated cocaine-evoked hyperactivity. Additionally, small hairpin RNA-mediated knockdown of presynaptic NMUR2 in the NAcSh using a retrograde viral vector potentiated cocaine sensitization. CONCLUSIONS: Together, these data reveal that NMUR2 modulates a novel gamma-aminobutyric acidergic pathway from the dorsal raphe nucleus to the NAcSh to influence behavioral responses to cocaine.
Authors: A M Wren; C J Small; C R Abbott; P H Jethwa; A R Kennedy; K G Murphy; S A Stanley; A N Zollner; M A Ghatei; S R Bloom Journal: Endocrinology Date: 2002-11 Impact factor: 4.736
Authors: Kathryn A Cunningham; Jonathan D Hommel; James M Kasper; Ashley E Smith; Sierra N Miller; William K Russell Journal: Neuropsychopharmacology Date: 2021-12-16 Impact factor: 8.294
Authors: Tim B Bigdeli; Ayman H Fanous; Yuli Li; Nallakkandi Rajeevan; Frederick Sayward; Giulio Genovese; Rishab Gupta; Krishnan Radhakrishnan; Anil K Malhotra; Ning Sun; Qiongshi Lu; Yiming Hu; Boyang Li; Quan Chen; Shrikant Mane; Perry Miller; Kei-Hoi Cheung; Raquel E Gur; Tiffany A Greenwood; David L Braff; Eric D Achtyes; Peter F Buckley; Michael A Escamilla; Douglas Lehrer; Dolores P Malaspina; Steven A McCarroll; Mark H Rapaport; Marquis P Vawter; Michele T Pato; Carlos N Pato; Hongyu Zhao; Thomas R Kosten; Mary Brophy; Saiju Pyarajan; Yunling Shi; Timothy J O'Leary; Theresa Gleason; Ronald Przygodzki; Sumitra Muralidhar; J Michael Gaziano; Grant D Huang; John Concato; Larry J Siever; Mihaela Aslan; Philip D Harvey Journal: Schizophr Bull Date: 2021-03-16 Impact factor: 9.306
Authors: Soo Min Kim; Soo Young Cho; Min Woong Kim; Seung Ryul Roh; Hee Sun Shin; Young Ho Suh; Dongho Geum; Myung Ae Lee Journal: Mol Cells Date: 2020-06-30 Impact factor: 5.034
Authors: Ashley E Smith; Kehinde O Ogunseye; Julia N DeBenedictis; Joanna Peris; James M Kasper; Jonathan D Hommel Journal: Sci Rep Date: 2020-12-16 Impact factor: 4.379